- Breaking News
- A ‘side-ways’ mechanism of detection in CD1a and γδ T cell receptor interactions
- A first-in-human antibody–drug conjugate: Hope for patients with advanced solid tumours?
- A map of the immune system
- A mechanism for severe COVID-19 in patients with obesity and diabetes?
- A nail in the coffin of (hydro)chloroquine treatment against COVID-19?
- A nanoparticle based vaccine for SARS-CoV-2 neutralization and protection
- A new cell type contributing to inflammatory skin diseases
- A new target for TB treatment with great potential
- A new TB vaccine – is it cost-effective and efficient?
- A new tool fight SARS-CoV-2: an ACE2-blocking antibody
- A new tool for predicting COVID-19 severity and prognosis
- A novel immunogene CD47-targeting therapy inhibiting tumour growth
- A novel inhibitor of dengue virus
- A novel pathway of immune and host cell evasion by Mycobacterium tuberculosis
- A potential end to peanut allergies?
- A potential mRNA vaccine for SARS-CoV-2 Omicron variant
- A potential new biomarker for Preeclampsia
- A potential new vaccine for rabies
- A recombinant adenovirus type-5 vectored COVID-19 vaccine appears safe and immunogenic in a first-in-human trial.
- A serological assay to detect SARS-CoV-2 seroconversion in humans
- A vaccine with a dual threat to cancer
- Ad26.COV2.S is safe and immunogenic
- Ad26.CoV2.S vaccine significantly boosts pre-existing SARS-CoV-2 specific antibodies but not CD4 T cell immune responses
- Adaptations of tissue-resident memory T cells
- Aged Neutrophils support tumor metastasis
- Aging & COVID-19
- Aiding Tuberculosis vaccine studies with the use of a mycobacterial growth inhibition assay
- Alzheimer’s Disease – a potential vaccine?
- An exuberant inflammatory host response to SARS-CoV-2 leads to COVID-19.
- An inflammatory pathway linked to autoimmune diseases
- An inventory of the vaccine candidates to SARS-CoV-2
- An update on the Shock and kill HIV cure strategy
- Animal models to measure mucosal innate immunity: zebrafish vs mice.
- Antibodies from cows may provide protection from Mycobacterium avium subsp. paratuberculosis
- Antibody profile in response to SARS-CoV-2 – serological profile and specificity of maternal and neonatal cord blood
- Antibody response to vaccination post-COVID-19 infection
- Antiretroviral therapy influences tumour development in patients with HIV
- Antiviral pathways induced in the RV144 vaccine trial
- Are blood groups associated with severe COVID-19 respiratory failure?
- Are CD8+ and DN MAIT cells distinct populations ?
- Are current putative COVID-19 vaccines effective against the B.1.351 variants?
- Are distinct monocyte subsets associated with severe Chagas diseases?
- Are Lung microbial products driving hyperinflammation in severe COVID-19?
- Are MAIT cells detectable in lymph?
- Are neutrophils in the tumor microenvironment friend or foe?
- Are polymorphisms in the ACE2 locus important for COVID-19 severity?
- ATLAS – describing SARS-CoV-2 variant T-cell responses
- Atopic dermatitis and the skin microbiome
- Atypical B cells as biomarkers of renal complication in lupus patients
- Auto-antibody responses to type I IFNs is a clue to severe COVID-19
- Axon regeneration in the adult nervous system – immune modulation
- B cell lymphomas and the role of TET enzymes
- B cell signalling deficiencies – new insights into treatments
- B-cell immunity against SARS-CoV-2 in unexposed individuals
- B-cell immunity following SARS-COV-2 mRNA vaccination – 6 months on…
- B1.351 (501Y.V2) induces cross-reactive Ab responses to other SARS-CoV-2 variants.
- BCG & COVID-19
- BCG induced trained immunity & COVID-19
- BCG reduces all-cause infectious diseases in the first 6 weeks of life in infants!
- BCG vaccination reduces infection in the elderly
- Bifonazole – a potential treatment for SARS-CoV-2 infection
- Biomarkers to identify Mycobacterium tuberculosis-infection: finding the needle in a haystack
- Blocking of an important coronavirus enzyme with natural compounds
- BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccine efficacy results
- Boosting of antibody responses against the V2 and V3 region of the HIV-1 Env
- Broad-spectrum Antiviral Inhibits SARS-CoV-2
- C5a-C5aR1 axis plays a role in cobra venom immunopathology.
- Can a Chimpanzee vector vaccine prevent SARS-CoV-2 pneumonia?
- Can a vaccine prevent ZIKV associated fetal abnormalities ?
- Can anti-HIV drugs, Lopinavir and Ritonavir, be used to treat patients with severe COVID-19?
- Can anti-α4β7 really “cure” SIV infection in ART interrupted NHPs ?
- Can BCG vaccination reduce mortality and morbidity from COVID-19?
- Can fat help us combat infection?
- Can intravenous-BCG prevent M.tb infection ?
- Can neonates born to mothers with COVID-19 acquire maternal infection ?
- Can neutrophils adopt antigen-presenting cell functions, and if so how?
- Can reprogramming CD8 T-cells contribute to a cure for a HIV?
- Can saliva be used to test for antibodies to SARS-CoV-2?
- Can some Tfh cells produce IFN-𝛾 ?
- Can the Cytokine Release Syndrome in COVID-19 patients be treated using CCR5 blocking antibody therapy?
- Can two FDA-approved drugs be re-purposed to clear SARS-CoV-2 infection?
- Can vaccinating cats against their own proteins reduce cat allergies in humans?
- Can we use cannabinoids to block SARS-CoV-2 viral entry?
- Cancer, collagen the microbiome and immunity – a link!
- Cannabidiol – a potential tool for fighting SARS-CoV-2
- Career Advice from IDA faculty that were once previous IDA Scholars
- CD229 CAR: New therapy for multiple myeloma
- CD27 expression identifies Th17 cells with high stemness properties
- CD8 T-cell mediated vaccine protection against SARS-CoV-2
- ChAdOx1 nCoV-19 vaccine is safe and immunogenic
- Changes in SARS-CoV-2 Omicron variant spike protein
- Chloroquine treatment and COVID-19
- Cigarette smoke triggers increased ACE-2 expression in the lung
- Class-switch recombination of antibodies occurs prior to germinal center formation.
- CNS-neuroinflammation: not all myeloid cells are responsible
- Comparing four COVID-19 vaccines
- Contributions to the understanding of the cellular immune response elicited by Brucella canis
- Convalescent plasma therapy for COVID-19 is safe.
- Convalescent sera option for containing COVID-19
- Could blood groups influence COVID-19 disease severity?
- Could infection with other viruses provide protection from SARS-CoV-2?
- Course Highlight: 5th Vaccinology in Course
- COVID-19 – Cytokine storm syndromes and immunosuppression
- COVID-19 & GIT symptoms
- COVID-19 & Multisystem inflammatory syndrome in children
- COVID-19 and idiopathic pulmonary fibrosis (IPF)
- COVID-19 and the brain – new insights
- COVID-19 Antibody Immunology Video
- COVID-19 in vitro studies: Use the right cell line
- COVID-19 is associated with increased MAIT cell activation and cytotoxicity
- COVID-19 mortality and genetic predisposition
- COVID-19 spurs interest in preprints and improves scientific collaboration
- COVID-19 vaccines: can alum based adjuvants improve induction of nAbs?
- COVID-19 Vaccinology Videos
- COVID-19: antigen-specific T cell response and immuno-metabolomic signatures
- COVID-19: extending or relaxing distancing control measures
- Critically ill COVID-19 patients show evidence for extrafollicular B cell activation
- Cytokine Release Syndrome & COVID-19
- DENV-infection induces two major CD8 T cell memory subsets
- Detection of autoantibodies in patients with multisystem inflammatory syndrome in children (MIS-C)
- Detection of SARS-CoV-2 nAbs in cats
- Developing an oral polio vaccine that does not cause vaccine-associated polio
- Developing monoclonal antibodies against SARS-CoV-2
- Developing new tools to combat COVID-19
- Development and use of cellular behavioural landscapes to describe inflammatory states
- Development of a potent SARS-CoV-2 nAb using llamas
- Development of a serological diagnostic of Johne’s Disease
- Development of an inactivated vaccine candidate for SARS-CoV-2
- Development of inactivated SARS-CoV-2 vaccines
- Development of natural murine model of Cryptosporidiosis
- Did you know neutrophils can help to form gallstones?
- Discovery of novel cancer signalling mechanism
- Distinct antibody responses as biomarkers to monitor cancer immunotherapies
- Do lipid bodies play a role in innate immunity?
- Do mutations in SARS-CoV-2 variants reduce the functional activity of mRNA-vaccine elicited Abs?
- Do mutations in the SARS-CoV-2 spike protein enhances viral infectivity?
- Do neutrophils play a role in age-associated increase in flu mortality?
- Do NK cells play a role in vaccine induced humoral immunity ?
- Do NK cells play an important role in anti-Trypanosomiasis immunity?
- Do SARS-CoV-2-specific T cells confer long-lived protection?
- Do we have more T cell immunity to SARS-CoV-2 than we think?
- Does ACE2 expression & cytotoxic lymphocyte levels indicate a risk factor for COVID-19?
- Does B.1.351 SARS-CoV-2 variant escape T cell immune responses?
- Does BCG improve de novo malaria immunity ?
- Does breast milk contain SARS-CoV-2?
- Does cancer immunoediting occur in humans?
- Does COVID-19 have a seasonal pattern?
- Does dysbiosis of the GIT microbiome enhance the neutrophils survival and chronic inflammation in HIV+ individuals?
- Does HIV superinfection induce an additive or synergistic Ab effect?
- Does HIV-env vaccination strategy affect the recognition pattern of IgG responses?
- Does mucosal BCG vaccination induce “protective” immunity ?
- Does mumps immunity induced by 2 doses of MMR wane in adulthood?
- Does S. mansoni treatment affect HIV susceptibility?
- Does serial administration of HIV-specific VRC01 bnAbs prevent HIV acquisition?
- Does the D614G mutation in SARS-CoV-2 spike protein result in the virus being more susceptible to neutralization by the host?
- Does the timing of granuloma formation affect TB control?
- Does whole cell pertussis vaccination skew infection induced Ab profiles?
- Dual BCR and TCR co-expressing lymphocyte could play a role in T1D pathogenesis.
- Dual bNAb therapy can maintain HIV viral suppression
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- Enhanced production of effective and personalised vaccines for cancer
- Enhancing the immune response: skin bacteria and the smallpox vaccination
- Epstein-Barr Virus found to trigger Multiple Sclerosis
- Evolution of flu-vaccine induced B cell responses
- Exaggerated immune response to Covid-19
- Exhaustion of antiviral NK and CD8 T cells in SARS-CoV-2 infection
- Exploratory study investigates the relationship between recent vaccinations and SARS-CoV-2 infection rates.
- Exploring characteristics of COVID-19 to guide public health policies & therapeutic interventions.
- Faecal shedding of SARS-CoV-2
- Fever: A positive regulator of Th17 mediated inflammation
- First report on Effectiveness of HPV Vaccination in LMICs – Rwanda and Bhutan
- Flynn Webinar: Immune features associated natural infection
- Flynn Webinar: What immune cells play a role in protection against M.tb re-infection?
- Formation of tertiary lymphoid tissue: fighting chronic inflammation
- Further Support of the Emerging “Immunologic” Hypothesis in Mood and Eating Disorders
- Gene editing as a potential sickle cell disease immunotherapy.
- Genetically modified Lactococcus lactis- A potential microbial therapeutic for acute colitis?
- Germline mutations in innate immunity associated with the risk for breast cancer: case of C-reactive protein
- Getting to the guts of SARS-CoV-2 infection
- GLA-SE promotes superior Tfh expansion than Alum
- Global ImmunoTalk on dissecting the interaction of parasites with the immune system
- Global Immunotalks Highlight: Immune responses after dengue virus infection: friend or foe?
- Granuloma formation during S.mansoni infection: protective or pathogenic?
- Gut Inflammation Linked to a Debilitating Skin Condition
- Hair growth and our immune system
- Have you heard of Mycetoma ?
- Have you heard of the ESAT-6 free IGRA ?
- Helminths and Vaccine responses
- Hematopoietic stem cell transplantation cures HIV
- HIV and its mechanisms of drug evasion
- HIV complications: inflamma-aging or increased activation ?
- HIV RV144 vaccine induces better responses in SA compared to Thailand
- HIV vaccine progress
- HIV Viral reservoir: quality rather quantity matters
- HIV-1 and TB coinfection skews the SARS-CoV-2 T cell response
- How are CD8 responses against the malaria liver stage antigens primed ?
- How DNA outside cells can be targeted to prevent the spread of cancer
- How do immune cells invade tissue?
- How does BCG affect early innate immune responses?
- How does group A Streptococcus evade immunity?
- How does IL-27 attenuate autoimmune neuroinflammation?
- How does plasmodial hemozoin contribute to cerebral malaria pathogenesis?
- How does SARS-CoV-2 evade the immune defences?
- How does the complement cascade result in pore formation in Lampreys
- How does vitamin A enter our intestinal immune cells and what are the implications?
- How effective is Dexamethasone for the treatment of patients with COVID-19?
- How Sickle-trait hemoglobin protects against severe Plasmodium falciparum malaria
- How the brain slows us down when we are sick
- How the Regulator is Regulated: Insight into immune-related Protein holds therapeutic value
- How the rice blast fungus “eats” its own cell wall to launch an attack
- How to boost immunotherapies against B-cell leukemia
- HPV & HIV infection are associated with high levels of activated CD4 T cells in the cervix uteri
- Human M1 macrophages champion the control of TB disease
- Hypothetical pathogenesis of SARS-CoV-2 infection in humans
- ICOS: is it essential for Treg-IL10 expression in the colon?
- IDA Highlight: CD4 T cells in HIV infection
- IDA Highlight: Current state of malaria vaccines
- IDA Highlight: Immune responses to TB vaccines
- IDA Highlight: Not all levels of malaria exposure induce the same anti-malarial immunity
- IDA Highlight: Possible barriers and opportunities for HIV cure
- IDA Highlight: Scanning the TCR repertoire to inform new TB vaccine targets
- IDA Highlight: What’s New in anti-HIV humoral immunity.
- Identification of D6R and C5aR2 as key molecules with the potential to combat inflammatory diseases
- Identification of two B cell epitopes that induce neutralising Ab in COVID-19 patients
- IL-25 blockade as a therapeutic strategy for asthma
- IL-7Rαlo KLRG1hi cells are not always short lived effector cells
- Immune memory in the intestine: new insights into “innate memory”
- Immune system evasion – the HIV-infected cell
- Immuno-Algeria 2020: Cellular components of the allergic response
- Immuno-Algeria 2020: Introduction to allergy and molecular diagnosis
- Immuno-Algeria: Allergic activity of IgE binding molecules
- Immuno-Algeria: Drug hypersensitivity in TB/HIV endemic settings
- Immuno-Algeria: IgE & its receptors as a pharmacological targets
- Immuno-Algeria: Microbial dysfunction & allergy
- Immuno-Algeria: Non-invasive allergy biomarkers & next-gen immunotherapies
- Immuno-Colombia: Anti-cytokine therapies (Part 1)
- Immuno-Colombia: Anti-cytokine therapies (Part 2)
- Immuno-Colombia: Checkpoint Blockade-based Therapies (Part 1)
- Immuno-Colombia: Checkpoint Blockade-based Therapies (Part 2)
- Immuno-Colombia: MDSCs promote tumour growth and escape
- Immuno-Colombia: Overview of immunotherapy
- Immuno-Colombia: Therapeutic cancer vaccines
- Immuno-Colombia: Tumour infiltrating lymphocyte therapy (Part 1)
- Immuno-Colombia: Tumour infiltrating lymphocyte therapy (Part 2)
- Immuno-Ethiopia: Anti-leishmania Immunity
- Immuno-Ethiopia: Fungal epidemiology and immunology
- Immuno-Ethiopia: Genetics of Fungal Immunology
- Immuno-Ethiopia: Malaria Highlight 1
- Immuno-Ethiopia: Malaria Highlight 2
- Immuno-Ethiopia: Sand flies & Leishmaniasis
- Immuno-Ethiopia: Xenodiagnosis of Leishmaniasis
- Immuno-Jaipur Highlight: MHC and Transplantation Immunology
- Immuno-Jaipur Highlight : Day 4
- Immuno-Jaipur Highlight : Part 2 of Day 4
- Immuno-Jaipur Highlight of talks by Abul Abbas
- Immuno-Jaipur Highlight: Clinical viral immunity
- Immuno-Jaipur Highlight: Insights into innate and adaptive immunity
- Immuno-Jaipur Highlight: Part 2 of Day 3
- Immuno-Jaipur Highlight: Primary immunodeficiencies
- Immuno-metabolism and cognitive decline
- Immunodiagnostic of onchocerciasis: do we have the right tool to end the game?
- Immunogenicity of heterologous SARS-CoV-2 vector vaccine prime-mRNA vaccine boost vaccination strategy
- Immunoinformatics Mexico 2019: Immunologic plasticity, defense lines.
- Immunoinformatics Mexico 2019: Part One
- Immunoinformatics Mexico 2019: Part Two
- Immunopaedia goes to the XIII World Immune Regulation Meeting
- Immunopathogenesis of Autoimmune Hepatitis
- Immunosenescence: how does it affect vaccine Ab responses ?
- Immunotherapy – new insights into how CD8+ T cells become unresponsive to treatment
- Impact of intermediate hyperglycaemia and diabetes on immune dysfunction in TB
- Improved cancer treatment response in those with COVID vaccination
- Improving Chagas disease diagnosis and treatment
- Improving existing malaria vaccines – new insights
- Improving treatments for autoimmune diseases
- Improving vaccine immunity against fungal pneumonia
- Inclusion of non-spike proteins in SARS-CoV-2 vaccines may be important for the induction of protective T cell memory.
- Increased activity of Neutrophil Elastase in sera of SLE patients during the COVID-19 pandemic
- Indian population could have intrinsic immunity to resist COVID-19 challenge
- Infection in the brain – defenses and consequences
- Inhibiting Mycobacterium tuberculosis infection
- Innate T cells & severe COVID-19
- Insights into the development of the blood and immune systems in prenatal bone marrow
- Investigating Ebola immunity using single cell technologies
- Investigating the HIV viral reservoir during acute infection
- Investigating the immunological composition of the Kidney
- Investigating the role of surfactants during TB using the lung-on-a-chip model
- Is a self-amplifying RNA SARS-CoV-2 lipid nanoparticle a good vaccine candidate?
- Is blocking inflammatory cell movement using chemokine receptor antagonists the way to go?
- Is COVID-19 an endothelial disease?
- Is the rapid generation of neutralizing antibodies to SARS-CoV-2 good news for preventing reinfection?
- Is there a role of T cells in immune protection to SARS-CoV-2 infection and COVID-19?
- Is there a SARS-CoV-2 receptor (ACE2) expression difference between males and females?
- Is tumour circulating DNA a better tool for cancer diagnostic and prognostic than immunological biomarkers?
- Is Yellow fever vaccination safe for HIV+ individuals?
- IUIS Beijing ICI 2019
- IUIS Webinar: Adaptive Immunity in COVID-19
- IUIS Webinar: COVID-19 & Immune Compromise
- IUIS Webinar: COVID-19 in South Africa
- IUIS Webinar: COVID-19 Monoclonal Abs
- IUIS Webinar: Global outbreaks – Interferons as 1st responders
- IUIS Webinar: HIV prevention- antibodies and vaccine development (part 1)
- IUIS Webinar: HIV prevention- antibodies and vaccine development (part 2)
- IUIS Webinar: Impairment of the immunological and neurological synapses by respiratory viruses
- IUIS Webinar: Involvement of C5a-C5aR1 axis in COVID-19 pathology
- IUIS Webinar: Longitudinal COVID-19 Immune Profiling
- IUIS Webinar: Predicting survival and severity of COVID-19
- IUIS Webinar: Respiratory Immunity and COVID-19
- IUIS Webinar: Role of cellular responses in COVID-19
- IUIS Webinar: Seeking correlates of COVID-19 protection and pathology
- IUIS Webinar: Stress dampens anti-viral immunity
- IUIS Webinar: Tracking SARS-CoV-2 in Ghana
- IUIS Webinar: Trained immunity and BCG vaccination: a tool against COVID-19?
- IUIS Webinar: Understanding Infection and Immunity of SARS-CoV-2
- IUIS Webinar: Utilising Ramos B cell engineering to measure SARS-CoV-2 Ab responses
- IUIS Webinar: What cancer immunologists are doing about COVID-19 ?
- IUIS-IIS-FIMSA-Immuno-Jaipur Report
- IUIS-Immunopaedia-Frontiers Webinar on Immunology taught by P. falciparum
- IUIS-Immunopaedia-Frontiers Webinar: Clinical representation of hyperinflammation
- IUIS-Immunopaedia-Frontiers webinar: Getting to the “bottom” of arthritis
- IUIS-Immunopaedia-Frontiers Webinar: Immunopathology of COVID 19 lessons from pregnancy and from ageing
- IUIS-Immunopaedia-Frontiers webinar: In-depth characterisation of immune cells in Ebola virus.
- IUIS/Immunopaedia-Frontiers Webinar on Immunoregulation and the tumor microenvironment
- JoAnne Flynn: BCG IV vaccination induces sterilising M.tb immunity.
- Kinetics of Immune Response in a Mild COVID-19 Patient
- Lack of interference by type I interferons leads to severe COVID-19
- Lack of sleep and your immune system
- Leaky gut in COVID-19 and its impact on Neutrophil Extracellular Trap formation
- Leukemia linked T cells may drive autoimmune diseases
- Lipid profiles key step to preventing breast cancer metastasis through epithelial-mesenchymal transition
- M.tb resistors: M.tb uninfected or atypical IFN-𝛾-independent M.tb immune responses ?
- Macrophages and Cervical Cancer: What’s going on with the microenvironment ?
- MAIT cells – a new target for future immunotherapies and vaccines
- Malaria Vaccine Breakthrough: Shaking or Stirring the Field?
- Male and female immune responses to SARS-CoV-2 substantially differ.
- Mask wearing to reduce the spread of COVID-19
- Measles induced immunological amnesia
- Meningeal-IgA+ plasma cells contribute to CNS-immunity
- Microbes prime foetal immune cells during early human development
- Microbial fitness and IgA – a balancing act for the intestinal flora
- Microglial cells – immune cells of the CNS breaking down harmful proteins in the brain
- miRNA carried by NETs modulate macrophage function
- Molecular mimicry: perfect match propels pathologies
- More SARS-CoV-2 variants?
- More than a gut feeling: The implication of gut microbiota in the pathology of Alzheimer’s Disease
- mRNA Vaccine against SARS-CoV-2 induces robust Ab responses
- Multi-organ damage is a hallmark of severe COVID-19
- Murine model of coeliac disease
- Mutation in the Spike protein may explain higher infectivity of SARS-CoV-2 and accelerated disease.
- Mutations in SARS-Cov-2 B.1.351 variant reduces vaccine induced Ab neutralisation
- Myeloid-derived suppressor cells: drivers of severe COVID-19 disease?
- Nasal spray immunisation: potential use against HIV and SARS-CoV-2 shown in an animal models
- Neurological effects of COVID-19
- Neutrophil dominance leads to protection from P. falciparum blood-stage merozoites
- Neutrophilic aid – extracellular traps to enhance macrophage directed bacterial killing
- Neutrophils as biomarkers for COVID-19 and recovery
- Neutrophils as potential early indicators of tuberculosis severity
- New fungus-derived antibiotic: relief in sight for immunocompromised people
- New hope – a potential new treatment for sepsis
- New Insights into the diagnosis, prognosis and monitoring of Multiple Myeloma: What’s the role of the Heavy/Light Chain Assay?
- New insights into the interferon response to SARS-CoV-2
- New insights into the role of HPV oncoproteins and immune response in cervical cancer
- News 2014
- A link between penicillin treatment in newborn infants and obesity
- A link between the gut microbiome and brain function?
- A systematic review and meta-analysis of long-term immune responses to vaccination in HIV
- Activation of HIV transcription in latently infected cells
- Agonistic induction of PPARy shown to reverse emphysema
- Airborne origins for Kawasaki disease
- Antibiotic treatment failure in four common infections- A primary care 1991-2012: longitudinal analysis
- ART in acute infection limits viral reservoirs
- Beta-catenin–regulated myeloid cells determine wound healing
- Broad-spectrum anti-biofilm peptide targets cellular stress response
- Can environmental non-TB mycobacteria interferes with immunity to TB?
- Cannabidiol-possible treatment option for acne
- CD45 ligation expands Tregs by promoting interactions with dendritic cells
- Characteristics of memory B Cells following HPV vaccination Immunity
- Characterization of pandemic influenza immune memory after vaccination or infection
- Clec12a regulates inflammation in response to cell death
- Club cells – identified in Influenza pathogenesis
- Control of Malaria-Induced Inflammation in Children is Dependent on Exposure.
- Dissecting tumor myeloid compartments to reveal APC critical for T Cell immunity
- EBV specific cytotoxic T Cell clones can transiently control EBV infection
- Efficacy of HPV vaccination in HIV positive adolescents and young adults
- Efficient 1-step radiolabeling of monoclonal antibodies for targeted radioimmunotherapy treatment of cancer
- Eradication of metastatic mouse cancers by suppression of myeloid-derived cell
- First-line boosted protease inhibitor regimen remains effective after virologic failure
- Fruit Bats and Flu
- Group B Strep selected and fixed through use of tetracycline
- Histone Deacetylase Inhibitors mark the ability of cytotoxic T cells to eliminate HIV
- HIV integration into the host DNA is not a random event.
- HIV sexual transmission risk among serodiscordant couples
- Immune-suppressant vaccine c blocks SIV infection in macaques
- Infectious Disease in Africa Symposium
- Inhibition of calcineurin abrogates whereas inhibition of mTOR promotes Regulatory T Cells
- Is there a link between Infertility and promotion of Sexually transmitted Infections?
- Kaposi Sarcoma treated with pegylated interferon
- Lopinavir/Ritonavir-based ART vs Efavirenz-based ART for the prevention of malaria in pregnancy
- Memory regulatory T cells reside in human skin
- Microbiota helps regulate behaviour in Autism Spectrum Disorders
- Mother–Infant HIV Transmission a review on antibody protection
- Mucosal and endotracheal delivery of RSV peptide prevents nasopulmonary infection
- Neuronal ferritin heavy chain and opiate abuse affect HIV-associated cognitive dysfunction
- Neutrophil crawling in capillaries- a novel response to MRSA
- New experimental vaccine looks promising for Dengue Fever
- New model for treatment of RSV
- New TB drug combination to enter late-stage testing
- Normalizing glycosphingolipids restores CD4+ T cells function in lupus patients
- Prostate cancer incidence among HIV-positive and HIV-negative men
- Protein kinase D2 amplifies T cell receptor–stimulated signaling in naïve CD8+ T cells
- Reliability and clinical relevance of HIV drug-resistance testing at low viraemias
- Renal function of participants in tenofovir study- Thailand
- Results from a novel flu vaccine
- Risk of Melanoma in People with HIV/AIDS
- Sex difference noted in response to influenza vaccine
- Short-term changes in HIV viral load and CD4+ cell count
- South African treatment guidelines should use viral load, not CD4 count for greater success
- Streptococcus pneumoniae forms microlesions in myocardium, disrupting cardiac function
- T cell differentiation regulated by methyltransferase G9A during murine intestinal inflammation
- T cell repertoire following autologous stem cell transplantation for multiple sclerosis
- T. gondii ligand shown to promote inflammatory monocytes and provide resistance to bacterial infection
- The role of Cas1 and 2 proteins and immunity
- Thibela TB study – a trial of mass Isoniazid preventive therapy for tuberculosis control
- TLR5-mediated sensing of gut microbiota has a role in response to flu vaccine
- Together muscularis macrophages and enteric neurons regulate gastric motility
- Tolerance or resistance to HIV infection? Which is it?
- Treating rhematoid arthritis with peptide-specific CD8+ regulatory T cells
- Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer
- Understanding molecular evolution of HIV and ART
- Using immunomics to find vaccine antigens for schistosomiasis
- UTI treatment requires a coordinated phagocytic response
- Vaccine-induced myeloid cell population dampens protective immunity
- Varicella Zoster Virus infection: Bad in adults
- Viral reservoirs limited by ART
- News 2015
- A new marker denotes exhausted CD8+ T cells during chronic viral infections
- A new reservoir of HIV found within peripheral Vδ2 T cells
- A new theory to explain autoimmunity: The Altered Glycan Theory of Autoimmunity
- Associations between infant chubbiness and Dengue Haemorrhagic Fever
- Can wearing silver damage your health?
- Diversity of lipid envelopes in Mycobacterium tuberculosis
- Do we need to re-think vaccine strategies to elicit anti-HIV antibodies?
- Extracellular vesicles as a vaccine candidate against Staphylococcus aureus infections
- Genetically modified commensal bacteria used as a possible HIV vaccine adjunct
- Herd Immunity: immunology meets public health
- Immune and viral events leading up to acute Infectious Mononucleosis
- Is Adipose Tissue a viral reservoir?
- Levels of PD-L1 Expression on target cells helps to establish viral latency
- Microbial Gut diversity predicts immune status during HIV-1 infection
- New antibodies that target sugars on the HIV-1 envelope
- New Mechanism underlying Rheumatoid Arthritis Pathogenesis
- Novel model provides quantitative explanation of CD4+ T Cells pathway in vivo
- Pregnancy Induces Activation of Aged Dormant Muscle Progenitor Cells
- Prevention of Mother-to-Child HIV transmission in African children in the first year of life
- Protecting Mucosal immunity in HIV positive people with combined CCR5/Integrase Inhibitors
- SIV infection of Tfh Cells in monkeys
- Stasis of CD8+ T Cells in the brain is a Signature of Cerebral Malaria
- Success of passive HIV immunization?
- The microbes within us – the microbiological niche of the lungs
- Trivalent Inactivated Poliovirus Vaccine (IPV) is Non-Superior to Live-Attenuated Oral Poliovirus Vaccine
- Why older people may succumb more readily to pneumonia
- World AIDS Day Message
- News 2016
- A combination of worms and bacteria may be good for your health
- A new genetic approach for diagnosing Common Variable Immunodeficiency
- A New Rapid Antigen Test for Human Bocavirus 1 (HBoV1)
- A novel immune mechanism of killing HIV infected cells
- A potential target for HIV reactivation discovered
- A promising new treatment for systemic lupus erythematosus (Lupus)
- AIDS 2016: Towards an HIV Cure
- Antibodies from Ebola survivor have potent anti-viral activity
- Antigen Delivery to the Draining Lymph Nodes is a Key to Intradermal Vaccination Efficacy
- Can we tolerate an inhaled vaccine as a way to improve BCG efficacy?
- Changes in CD8 T cells during viral infection
- Characteristics of HIV which affect antibody recognition
- Chikungunya virus vaccine using an insect virus
- Combination Antibiotic and Pidotimod Therapy against Pneumonia
- Do Mosquito bites help viral infections?
- Does Chlamydia infection result in increased HIV susceptibility?
- Ebola vaccine confirmed to be highly effective
- Financing the Response to HIV: Show Us the Money
- Gut microbiota influences pathogenesis of Parkinson’s disease
- Gut microbiota suppress liver cancer
- HIV R4P Highlights: New antibody lineages against HIV high mannose-patch
- HIV R4P Highlights: BV increases risk of HIV acquisition through neutrophils
- HIV R4P Highlights: Children frequently make HIV-specific broad antibody responses
- HIV R4P Highlights: Dendritic cells which capture HIV in Female Reproductive Tract
- HIV R4P Highlights: HIV superinfection does not increase antibody breadth
- HIV R4P Highlights: Inducing T cells in an HIV Vaccine
- HIV R4P Highlights: Interview with Prof Thumbi Ndung’u
- HIV R4P Highlights: α4β7 antibody and ART: a novel HIV therapy
- HIV uniquely impacts on gut microbial metabolism
- ICI 2016 – Parasitic worms in the treatment of chronic asthma
- ICI 2016 – Potential new diagnostic tool for TB in children
- ICI 2016 – Reversing Schistosomiasis Tissue Fibrosis
- ICI 2016 – The Future of a More Effective HIV Vaccine?
- ICI 2016 – The role of complement in fighting malaria in pregnancy
- ICI 2016 – What is the link between house dust mites and allergic disease?
- ICI 2016 – What leads to HIV progression in children?
- ICI 2016- Mycobacterium tuberculosis at the granuloma level in the human lung
- IgA antibodies found in women taking PrEP
- Immune Ontogeny and the microbiome
- Immunological memory in the Mucosa
- Immunopaedia goes to the 21st International AIDS Conference
- Infants can produce anti-HIV antibodies with minimal somatic hypermutation
- Inflammatory markers during pregnancy is linked with autism
- Injection drug use and susceptibility to HIV and co-morbidities
- Insights into how hemolysis leads to susceptibility to infection
- Intact Ovine Immunoglobulin (EBOTAb) to Treat Ebola Virus Infection?
- Is an HIV vaccine possible?
- Is there a link between loneliness and Inflammation?
- Mosquitos with fungus are more susceptible to malaria parasites
- Mycobacterium tuberculosis tricks body into autoimmunity
- Neutrophils and radiation therapy working together to fight cancer
- Nucleoside reverse-transcriptase inhibitors (NRTIs) as first-line ART in African Children
- Possibility of one vaccine to prevent Zika and Dengue viruses
- Possible mother-to-child transmission route for Zika virus discovered
- Progress in HIV Vaccines and the Road to the Clinic
- Reflecting on AIDS 2016
- Regulation of IL-25 levels provides protection against clostridium difficile infection
- Solving the 50-year-old riddle: the link between Plasmodium falciparum Malaria and Endemic Burkitt’s Lymphoma
- Targeting essential TB enzyme may lead to novel treatments
- Th1 response leads to effective antibodies against influenza
- The adverse effects of Zika virus on infants
- The link between malaria and cancer
- The microbiome has anti-tumor effects
- The role of TNF and aging in susceptibility to infection
- Toll-like receptor helps nematodes avoid pathogens
- Treating AIDS in 2016: New drugs for the future
- Treating helminth infections boosts immune system
- Treating HIV with the power of an antibody
- Understanding the organization of TB-associated granulomas
- Understanding the skin phenotype of children with eczema
- Unique T cells compartmentalize in lymphoid sites
- Using CARs to kill HIV
- Using cell-specific knock-outs to study the function of genes
- Using nanoparticles in HIV immunogen design
- Vaccine: Protective Measures Against Chlamydia Discovered
- What causes the high mutation rates of HIV-1 in the human body?
- News 2018
- Potential treatment for metastatic colorectal cancers: T cell engaging bispecific antibodies
- 2018: The year of hope for TB vaccines
- 5GFTB Highlights: Can we immunologically distinguish LTBI, EPTB and PTB
- 5GFTB Highlights: Can we induce BCG-mediated long term innate immunity
- 5GFTB Highlights: Human TB Challenge, is this possible?
- 5GFTB Highlights: MTBVAC potential BCG replacement
- 5GFTB Highlights: Recombinant BCG-Esx1 can induce CD8 T cell responses
- 5GFTB Highlights: Why is a new vaccine against TB important?
- A novel function of the antihelminthic drug Praziquantel: new strategy for combatting schistosomiasis
- ALAI/SMI congress: Hosts a Nobel Laureate and the 1st Iberoamerican Flow Cytometry Meeting
- ALAI/SMI Highlight: Have you heard of IL-40?
- Another use for BCG, potential Diabetes cure?
- Antibodies and TLR7 agonist delays HIV viral rebound
- Antibody-based vaccine protects against 31% of HIV isolates
- Are alveolar macrophages M1 or M2 polarised?
- Article Highlight: Differentially Expressed Host linc RNA and mRNA in HIV-1 and HIV-2 Infection (Santanu et al., 2018)
- Can antibiotic treatment improve Rotavirus immunogenecity?
- Can B cell responses predict resolution of Lyme Disease?
- Can CXCL4 contribute to autoimmune pathology?
- Can platelets directly kill Plasmodium sp. ?
- Can profiling CD8 T cell responses from Ebola Survivors improve vaccine design?
- Can testosterone regulate B cell numbers?
- Can viral Immunogenicity govern DENV epidemiological fitness ?
- Cancer Immunotherapy is associated with changes in innate immunity
- CD32: marker of HIV reservoir?
- CD4 T cell positioning in TB granulomas matters
- CD45.1 vs CD45.2 B6 mice more than an isoform difference.
- Characterisation of porcine conventional DC subsets
- Clade C RV144-like vaccine is immunogenic.
- Commensal bacteria leverage IgA during colonisation
- Comparing H56 responses in NHP and humans using mathematical modelling.
- Cyto2018 Highlight: Immune Clock of Pregnancy
- Cyto2018 Highlight: Phenotyping DCs using 30 markers.
- Dengue specifc-CD8 T cell responses but not Abs provide protection against Zika
- Do monocytes contribute to heamolytic ureamic syndrome?
- Does CXCL17 contribute to protection against herpes ?
- E-cigarettes may not be a healthier alternative to traditional cigarettes.
- ECTS2018 – Where scientific research and clinical practice meet
- Engineering IL-2 cytokine-receptor complexes to improve cancer immunotherapy
- Fatal SFTSV is associated with defective B cell responses
- First Animal Model of Rasmussen’s encephalitis
- H5VLP-GLASE unlike H5VLP-alum induces both Ab and T cell responses
- Harmless γδ T cells associated with Corynebacterium sp. can be harmful during immune dysregulation
- Have you heard of analytic treatment interruption of HIV ART?
- Have you heard of TPMs?
- Have you heard of trained immunity?
- HIV Env immunogens elicit broad antibody responses in animal models
- HIV vaccine induces similar responses in humans and rhesus macaques.
- How do mesenchymal stem cells alleviate severe asthma symptoms?
- How do tuft cells induce Type 2 Responses?
- How do γδ T cells control humoral immunity ?
- How does alum block induction of Th1 cells ?
- How does anti-TNF treatment affect TB granuloma formation?
- How does bacterial-viral co-infection impact anti-viral immunity?
- How does hyperglycemia lead to aggressive cancer?
- Human mAbs protects against Zika Neuropathology in Mice
- IDA Highlight: TB is a complex disease
- IDA Highlights: HIV Immunity
- IDA Highlights: Immune responses at mucosal sites
- IDA Highlights: Innate signatures of HIV vaccines
- IDA Highlights: Malaria
- IDA Highlights: TB vaccines
- Identifying disease-associated populations in the age of big data
- IgD: the lesser known antibody
- ILCs homeostasis in Psoriatic Arthiritis
- Immunological T and B cell Diversity of the Human Penis
- Immunopaedia goes to the Latin American Immunology Congress
- Immunoregulatory effects of Vitamin B5 during M.tb infection
- Improved T cell detection by Peptide-MHC dodecamers compared to tetramers
- Improved tetramer staining protocol detects functional T cells with low affinity TCRs
- Influenza-specific lung resident CD8+ T cells maintain diverse TCR profiles
- Influenza-specific lung TRM maintain diverse TCR profiles
- Initial Immune Responses to TB in the Human Lung
- Intestinal helminth co-infection promotes control against lung migrating parasites
- Is CD153 essential for M.tb control ?
- Is kick-and-kill HIV cure strategy achievable?
- Latin American Immunology Congress, a cocktail of scientific breaking news.
- Local signals matters: implication for CD8 T cell function against Leishmania
- Lower efficacy of tumour immunotherapy in obesity is due to elevated Leptin
- MAIT cell dysfunction during primary sclerosing cholangitis
- MAITs respond differently to ZIKV and DENV
- Measuring T cell proliferation using the “Warburg” effect.
- Metabolic reprogramming: Novel strategy to improve cancer immunotherapy
- MGIAs: potential role of trained immunity ?
- Natural infection improves breadth of vaccine induced memory
- New Hope for TB Vaccines
- New hope from chronic HBV patients: non-replicative Ad-HBV vaccine
- Non-cytotoxic function of HIV-specific rectal CD8+T cells
- Not all RV144 vaccine induced IgA responses are bad.
- Omentin-1 rescues inflammation-induced osteoporosis
- Ontogeny of MAITs
- Oral vs intradermal BCG, what’s the difference?
- Organ specific replenishment of tissue resident macrophages
- Paratuberculosis in Cattle: Differences in WC1+ γδ T cells responses to stimulation with PPD-J
- Patho-physiological implication of NET in COPD patients
- Phase 1 Zika vaccine trial shows promise
- Plasmablast formation: which T helper phenotype is important?
- Potential therapeutic use of H. pylori for asthma
- Profiling MAITs during Multiple Myeloma
- Public Antibody Clonotypes observed in HIV+ individuals.
- Re-developed live attenuated Cholera vaccine, is it safe?
- Reduced Flu severity due to high fibre diet
- Resident CD8+ T cells restrain HIV replication in elite controllers
- SAHGP Pilot: Southern Africans are more diverse than expected
- Serum IgA induced by commensal microbes protects against sepsis
- T follicular helper cells are essential for generating nAb during chronic-infection.
- T-bet expression negatively affects T cell lung homing during TB
- TLR-agonist and Salmonella are potential antimelonoma immunotherapy
- Tuft cell tropism may aid norovirus pathogenesis
- Understanding follicular CD8 T cells during SIV infection
- Vaccine induced monocyte activation contributes to decreased risk of SIV acquisition
- We are at the IDA this Week
- We need new HAB/HBV vaccine strategies for HCV/HIV infected individuals.
- What is the incubation period of TB?
- What’s behind Eosinophilic Esophagitis?
- Where do uterine NK cells during pregnancy come from?
- Which cells contribute to immunity against vaginal Zika infection ?
- α4β7-MAdCAM interaction promotes HIV replication.
- NIH COVID-19 lecture on SARS-CoV-2 mRNA vaccine
- NIH COVID-19 lecture on SARS-CoV-2 neutralising antibodies
- NIX is essential for systemic metabolic reprogramming of immune cells mediating tuberculosis protection
- No evidence that BCG vaccination can protect against SARS-CoV-2 infection.
- Non-invasive tumour immune cell monitoring
- Not all SARS-CoV-2 mutations lead to reduced antibody neutralisation capacity
- Novel HIV-1 variant found in Netherlands: the implications
- Novel insights – regulating skin inflammation
- Novel insights: immunotherapy responses in lung cancer
- Novel protein linked to rheumatoid arthritis pathogenesis
- Novel treatment approach for asthma without negative immune system effects
- Novel vaccines induce neutralising antibodies against Epstein-Barr virus in mice
- Our natural defence to skin cancer – new insights
- Ovarian cancer and immune evasion
- P.falciparum secretes extracellular vesicles with functional 20S proteasomes to prime RBCs for parasite invasion
- PD-1/PDL1 pathway in the maintenance of maternal-foetal immunotolerance
- Pfizer and BioNTech COVID-19 vaccine
- Phase 2a trial provides evidence for potential pancreatic cancer immunotherapy
- Potent neutralising antibodies against SARS-CoV-2 variants of concern.
- Potent neutralizing antibodies isolated from COVID-19 patients
- Potential SARS-CoV-2 & COVID-19 Vaccines
- Potential vitiligo immuno-therapeutic: antigen-specific CAR-Tregs
- Pre-clinical evaluation of a vaccine that induces both SARS-Cov-2 and yellow fever virus immunity.
- Predicting patient responses to COVID-19 immunotherapies
- Predicting response to immunotherapy in patients with clear cell renal cell carcinoma (ccRCC)
- Predicting tissue graft outcomes using immune markers
- Predicting transplant rejection using proteoforms
- Pregnancy and its influence on the immune response to SARS-CoV-2
- Pregnant women show elevated levels of anti-inflammatory glycosylation patterns of IgG antibodies
- Promising new insights: the immune response following a stroke
- Promotion of protective anti-tumour CD8+ T cell immunity – a new treatment for tumours
- Propagation of α-synuclein from the gut to brain – new causation for Parkinson’s disease?
- Rapid decay of IgG to SARS-CoV-2 in people with mild COVID-19
- Rebound to COVID-19 – not from impaired immunity
- Recurrent Strep throat: when TFH cells “turn on” you
- Reprogramming the Tumour Microenvironment – Improving Cancer Survival
- Repurposing of a drug for alcoholism to treat cancer
- Researchers may have found a way to “cure” cat allergies?
- Resistance to key antimalarial drug?
- Respiratory disease and viral shedding in rhesus macaques inoculated with SARS-CoV-2
- Rethinking HIV remission strategies: end of the road for anti-α4β7 ?
- RNA-based vaccine BNT162b1 induces robust IgG and T cell immunity
- Roles of different anti-SARS-CoV-2 antibodies in COVID-19 disease and protection
- Safety and immunogenicity of Sputnik V vaccine
- Safety and immunogenicity of the Ad26.COV2.S COVID-19 vaccine candidate.
- Safety and immunogenicity of the SARS-CoV-2 mRNA-1273 vaccine candidate in older age.
- Safety considerations in laboratory practice when testing specimens from patients suspected or infected with SARS-CoV-2
- SAIS/Immunopaedia COVID-19 Webinar on Severe vs mild COVID-19 immunity, and intersection between Nicotinamide pathway & COVID-19.
- SAIS/Immunopaedia Webinar on BCG & COVID-19
- SAIS/Immunopaedia Webinar: Antibody responses and serology testing
- SAIS/Immunopaedia Webinar: COVID-19 Vaccines
- SAIS/Immunopaedia Webinar: Immunothrombosis & COVID-19
- Saliva viral load could be a potential correlate of severe COVID-19
- SARS-CoV-2 – a weakness?
- SARS-CoV-2 and mucosal immunity
- SARS-CoV-2 and partial resistance to remdesivir
- SARS-CoV-2 and T-cell escape
- SARS-CoV-2 can infect adipose tissue
- SARS-CoV-2 found in semen.
- SARS-CoV-2 infection following vaccination – more robust immunity
- SARS-CoV-2 infection in young children and Kawasaki-like disease.
- SARS-CoV-2 monkey model shows protection from re-infection.
- SARS-CoV-2 monoclonal antibodies as potential COVID-19 treatment.
- SARS-CoV-2 mRNA-1273 vaccine shows signs of potential efficacy
- SARS-CoV-2 omicron variant hardly evade neutralization by S309
- SARS-CoV-2 Omicron variant in hamsters is not as deadly as we think
- SARS-CoV-2 serological assay on-a-chip.
- SARS-CoV-2 transmission and mask wearing.
- SARS-CoV-2 transmission exploits existing secretory pathways in the nasal cavity: a vaccine/drug target?
- SARS-CoV-2-specific IgG and IgM in asymptomatic individuals wane quickly
- SARS-CoV-2-specific Memory B cells persist up to 8 months post infection.
- SARS–CoV-2 infection of the placenta
- Scientific Response to COVID-19 Video
- SEPSIS is WANTED!
- Sex associated differences to flu vaccination: role of estradiol?
- Should we consider aerosol vaccines for COVID-19
- Should we consider SARS-CoV-2 human challenge models for vaccine testing ?
- Single-cell RNA-Seq of BAL samples from COVID-19 patients
- SOLIDARITY TRIAL: Testing existing drugs to treat COVID-19
- SOLIDARITY TRIAL: WHO COVID-19 treatment trial
- Solving the puzzle of IgG4-related disease, the elusive autoimmune
- Statins: improved survival rates and reduced mortality rate in COVID-19 patients.
- Stopping inflammation in its tracks
- Strain specific host restriction of recurrent UTIs
- Sugar and autoimmune diseases: what are the risks?
- Susceptibility of domestic animals to SARS-Cov-2
- T cell activation as a potential surrogate marker for TB treatment efficacy.
- T cell lineage fate is driven by CD4 and CD8 co-receptor gene loci
- T cells altered by CRISPR may be safe to use in cancer patients
- T cells and melanomas – a potential predictive tool
- T cells and skin disease
- T-cell response to SARS-CoV-2 Omicron
- TAK-003 induces functional DENV cross-reactive cellular immmunity
- Targeting COVID-19 immunopathology using rapamycin
- Targeting the metabolic profile of latently infected macrophages as a potential treatment for HIV
- TB biomarker based on anti-Ag85B and 4 inflammatory molecules.
- TB diagnosis in children: metabolite biomarkers
- TB episode following PD-1 blockade
- TB treatment with diabetes comorbidity: new insights
- Testing potential neonatal sepsis drugs using a murine neonatal sepsis.
- Th17 and Multiple Sclerosis (MS)
- The “topology” of the immune response to COVID-19
- The (Un)usual Suspect-Novel Coronavirus Identified
- The antibody response to SARS-CoV-2 501Y.v2 variant and vaccine implications
- The current status of COVID-19 immunology
- The different clinical characteristics of COVID-19 between children and adults.
- The emergence of inflammatory monocytes as the leukemia anteroom.
- The emerging role of IL-26 in fighting against intracellular microbes
- The humoral response as a marker in patients with chronic obstructive pulmonary disease
- The Immune Function of Osteoclasts
- The immune system and obesity
- The interplay between LRRC15+ myofibroblasts and anti-tumour immunity
- The opportunity to boost antiretroviral therapy interventions through maternal vaccination
- The Origin of SARS-CoV-2
- The potential benefit of high-dose intravenous Ig in severe COVID-19
- The role of complement in COVID-19 pathogenesis.
- The role of emergent food allergies in rethinking vaccine strategies
- The role of Galectin-3 in the tumor microenvironment
- The role of the PD-1 blockade in Mycobacterium tuberculosis infection
- The Vaccinology course, if you are in the vaccine-world, you shouldn´t miss it!
- Time of day for COVID-19 vaccination does not matter
- Tissue tolerance in COVID-19
- Toothpaste – a trigger for gut inflammation
- Toxoplasma gondii-Induced Neutrophil Extracellular Traps Activate Neutrophils and promote T cell recruitment
- Trained Immunity in Dogs.
- Treating COVID-19 with immunoglobulins, should we be cautious?
- Treatment with interferon-λ confers protection from SARS-CoV-2 variants – Beta and Omicron
- Tumor associated macrophages: the future targets for anti-melanoma immunotherapy ?
- Type I interferon co-stimulation of MAIT cell function
- Uncertainty is hampering doctors’ ability to treat COVID-19
- Understanding the immune system and COVID-19: New insights
- Unique genes: the innate immune response and tuberculosis
- Use of future liposomal cancer oncology treatment
- Using bacteria to fight cancer
- Using lipid nanoparticles for cancer treatment
- Using viruses to fight cancer
- Uterine NK cell differentiation during the menstrual cycle and pregnancy.
- Vaccine elicitation of engineered HIV-specific B cells: inducing bnAbs
- Vaccine-associated enhanced respiratory disease in hamsters vaccinated against COVID-19
- Variations in leukocytes – three months following mild COVID-19 infection
- Vimentin and its role in COVID-19 infection
- Viral dynamics in mild vs severe COVID-19
- We need innovative tools to diagnose Coeliac disease
- Webinar on harnessing innate immunity from cancer therapy to COVID-19
- What can ZIKV-CD8 T cells do ?
- What determines COVID-19 disease persistence and severity?
- What does HIV infection have to do with T follicular regulatory cells (TFRs)?
- What does HLA-DR expression on CD4 T cells indicate?
- What effect does anti PD-1 therapy have on responses to the influenza vaccine?
- What evidence is there for pre-existing antibody responses to SARS-CoV-2?
- What happens to your cilia during SARS-CoV-2 infection?
- What other disease affect individuals with olive pollen allergies?
- What role do CD137L and CD4 T-cells have in B-cell lymphoma immuno-surveillance?
- Where did SARS-CoV-2 come from?
- Where do memory B cells get reactivated?
- Where is single cell genomics taking the field of Immunology?
- Which COVID-19 vaccine will be the most effective?
- Why are hypertension and diabetes patients at high risk of severe COVID-19?
- Why do people with the Dantu blood group have a lower risk of developing malaria?
- Why is COVID-19 so mild in children?
- Why is flu vaccine induced immunity short-lived?
- Why is SARS-CoV-2 Omicron less severe than Delta?
- Wild is better: in-bred mice born to wild mice resemble human responses
- Will the COVID-19 pandemic result in significant neuropsychiatric sequelae?
- WNT7A: The new marker for resting T cells
- World Hepatitis Day: proof of concept HCV nanoparticle vaccine
- WORLD TB DAY: COVID-19 & TB
- News 2017
- 2nd Annual International Remote Conference: Science and Society
- A Broad Overview of HIV Treatments and Cures
- Alere HIV Combo Rapid Test
- Allergy and asthma across generations
- Antibodies protect against cytomegalovirus infection
- Antibodies with incomplete neutralization protect against SHIV
- Antibody cocktail to prevent Zika infection in pregnant women
- Antibody resistance does not play a role in mother-to-child-transmission
- Antibody that can control HIV replication
- Antibody-drug dual combination to fight cancer
- Application for CRISPR in muscular dystrophy
- Asthma increases susceptibility to influenza
- Asymptomatic Zika virus infection protects from re-infection
- Block-and-lock strategy to cure HIV
- Breastfed children less susceptible to asthma attacks
- Broad antibodies from HIV-infected individuals
- Cancer-killing viruses: the future of cancer therapy?
- Candidate heroin vaccine effective in primate model
- CD161+CD4+ T cells depleted at the Cervix during HIV Infection
- CD8 T cells are important for Zika virus control
- Cell-to-cell HIV transmission evades antibody responses
- Cerebral cavernous malformations enhanced by microbiome
- Changes in gut microbiome in Inflammatory Bowel Disease
- Characterization of novel antibody that recognizes HIV trimer
- Child maintains HIV remission without drugs
- Combination of 2 antibodies controls HIV replication
- Conventional antibody can neutralize HIV
- Cow immunizations generate broad HIV antibody responses
- Cross-reactive antibodies for Ebola vaccine
- CXCL13 predicts development of HIV-specific antibodies
- Deletion of TB protein eliminates cell heterogeneity
- Diabetes vaccine in sight
- Different gut microbes present depending on diet
- Dorsal foreskin cutting for effective HIV prevention
- Dysfunctional B cell subsets in TB patients
- Early Introduction of Peanuts Prevents Allergies
- Effect of BCG vaccination on HIV-exposed infants
- Effective mechanism to kill human viruses
- Elevated Th17 cells in “healthy” overweight children
- Engineered CD8 T cells flush out HIV reservoirs
- Environmental factors associated with asthma development
- Evidence for antibodies in control of HIV infection
- Expression of CD40L by CD8 T cells promotes autologous activation and differentiation
- Functional antibody immunity 40 years post Ebolavirus exposure
- Functional B cells needed to prevent preterm birth
- Garlic treats dengue virus inflammation
- Glycosylation consensus to aid HIV immunogen design
- GM-CSF and neuroinflammation
- Gonorrhoea superbug on the rise globally
- Gut bacteria induce pro-inflammatory response in MS
- Helminth protection by innate Type 2 immunity
- High salt intake linked to graft rejection
- Highlights from the Infectious Disease (ID) Week 2017 Conference
- Histamine releasing factor makes host vulnerable to malaria
- HIV escapes by novel mechanisms
- HIV immunogen based on precursor antibodies
- HIV Nef protein implicated in cardiomyopathy
- HIV PrEP Linked to Kidney Function
- HIV vaccine design with less mutated antibodies
- How effective are anti-TNF-α agents in treating sarcoidosis?
- How Tregs control liver damage
- HPV E7 protein downregulates antitumour immunity
- HPV-positive cancer cells are dormant in low oxygen conditions
- Identical viruses form HIV reservoir
- IL-10+ Th1 T cells associated with reduced malaria parasitemia
- IL-17RA deficiency and susceptibility to pathogens
- IL-4–producing B cells shift T cells to Th2 responses
- Immunomodulatory effect of lactic acid on the female reproductive tract
- Immunopaedia, the Official IUIS Learning Site
- Important role for antibodies in TB infection
- Inflammation associated with chronic fatigue syndrome
- Insight into immune activation caused by Ebola virus
- Interaction between microbiome and urogenital schistosomiasis
- International Remote Conference Highlights: Antibody response to malaria in Burkina Faso
- International Remote Conference Highlights: Can HAART be used to cure HIV?
- International Remote Conference Highlights: Establishment of memory CD8 cells to influenza
- Investigating HIV RNA expression during antiretroviral therapy
- Is HIV becoming more resistant over time?
- Lab mice may be too clean to use in studies
- Langerhans cells affect HIV transmission
- Link between schistosomiasis and HIV susceptibility
- Lung on a chip model recapitulates lung cancer pathology and therapy
- Malaria vaccine trial with promising results
- Malaria-induced anaemia reinforced by treatment
- Marginal zone B cells in cholesterol control
- Marijuana May Decrease ART Adherence
- Meat Allergy Develops from Tick Bite
- Mechanism behind malaria-induced autoimmunity
- Memory responses are not restricted to immune cells
- MHC Ib molecule protects against TB infection
- Microbiota in T cell survival
- Microorganisms in the eye protect against infection
- Microvilli in T cell activation
- mTOR implicated in the onset of asthma
- Mucosal cells enhance HIV entry into CD4 T cells
- Multi-site injections enhance immune responses
- Mycobacterium tuberculosis diversity
- MyD88-mediated cells against C. rodentium identified
- Neutrophils aid in immune tolerance during pregnancy
- New autoimmune disease driven by thymic tumour
- Next-generation RTS,S-like malaria vaccine
- No correlation between Vitamin D levels and vaccine responses
- No role for CD4 T cells in shift from latent to active TB
- Not all CD8 T cells have cytotoxic effects
- Novel cell population reduces response to tumours
- Novel mechanism for anti-cancer drug
- Novel mechanism reveals how leishmania evades immune system
- Optimizing HIV immunization strategies
- PD-1-based immunotherapy affected by gut microbiome
- Pharmacological treatment of lymphedema
- Plasmodium infection promotes bone loss
- Polyfunctional antibodies in the control of HIV
- Potential serological test capable of distinguishing Zika from Dengue infections
- Pre-diabetes associated M.tb-specific T cell dysfunction
- Preterm births alter ATP production and immunity
- Probiotic lotion as eczema treatment
- Probiotics induce double-positive intraepithelial lymphocytes
- Rapid evolution of the infant microbiome after birth
- Reason why immunotherapy does not work for all cancers
- Recycling of B cells in the humoral immune response
- Regulatory T cells delay clearance of malaria through CTLA-4
- Regulatory T cells help prevent CMV reactivation
- Reprogrammed T cells kill cancer
- Resident T cells improve melanoma prognosis
- Road to an effective HIV immunogen
- Role of horsepox in smallpox vaccine
- Role of IL-7 receptor in tuberculosis
- Role of T cells in Zika virus infection
- RTS,S/AS01E induces robust central memory responses to HBsAg but not to CSP
- Sensitive Zika virus diagnostic method using whole blood
- Severity of leishmania infection depends on time of day
- Short chain fatty acids improve inflammation of the eye
- Targeting an integrin as a potential HIV therapeutic
- Terminal differentiation of T cells during CMV & HIV infection
- The nutritional consequence of HIV-helminth coinfection
- Traits associated with the production of broadly neutralizing antibodies
- Transphagocytic CD4+ T cells are true APC capable of inducing functional CD8 memory cells
- Trispecific antibody for HIV therapy
- Type I interferons are important in anti-helminth Th2 immunity
- Type III IFNs in Hepatitis E persistence
- Using chemokine CXCL13 as a biomarker of germinal centre activity
- Vaccine induced T cell immunity, antigen localisation in bacterial vector matters
- Vaginal Microbiome Affects HIV Prevention
- Zika virus persists in cerebrospinal fluid and lymph nodes
- Zika virus replication in female genital tract
- Whole M.tb inherently induce highly differentiated T cells compared to H56 vaccination
- Kai 1 and Kai 2, new Dog Erythrocyte Antigens: implications for clinical practice
- Contact Us
- Donate Now
- Events
- Immunopaedia – Free Immunology Education
- Latest Interviews
- Audio Interviews
- Clara Gorodezky Interview
- Eleanor Fish Interview
- Georg Hollander Interview
- Güenter Fröeschl Interview
- Guido Ferrari Interview
- Heather Jaspan Interview
- Henry Mwandumba Interview
- Ido Amit Interview
- Jeffery Dorfman Interview
- Olivera J. Finn Interview
- Reto Guler Interview
- Richard Koup Interview
- Susan K Pierce Interview
- Timothy Ray Brown Interview
- Wendy Burgers Interview
- Immunologist of the Month – 2016
- Immunologist of the Month – 2017
- Bob Hancock Interview
- Dhafer Laouini Interview
- Eltahir Awad Gasim Khalil Interview
- Faith Osier Interview
- Gary Entrican Interview
- Hatem Masmoudi Interview
- Jean-Philippe Julien Interview
- Juan Carlos Zúñiga-Pflücker Interview
- Michelle Letarte Interview
- Mohlopheni Jackson Marakalala Interview
- Narinder Mehra Interview
- Rajesh Ringe Interview
- Immunologist of the Month – 2018
- Jacqueline Marvel Interview
- Jean-Marc Cavaillon Interview
- Luis F. García Interview
- Manuel A. Franco Interview
- María Moreno Interview
- Nashied Peton Interview
- Olivier Boyer Interview
- Pascale Kropf Interview
- Paul W. Kincade Interview
- Pierre Van Damme Interview
- Sarah C. Gilbert Interview
- Stanley Plotkin Interview
- Immunologist of the Month – 2020
- Immunologist of the Month – 2021
- Immunologist of the Month – 2022
- Immunologist of the Month- 2019
- Video Interviews
- ALAI/SMI Special Video Interviews
- Carla Rothlin and Elina Zuniga
- Claire J Hoving Interview
- David Sacks
- Erica L Johnson
- Fabienne Tacchini-Cottier Interview
- Gama Bandawe Interview
- Hans-Martin Jäck Interview
- Immunoinformatics 2019 Course
- Michele A. Miller Interview
- Olabanji Surakat
- One B. Dintwe Interview
- Simon J. Draper Interview
- Virginie Rozot
- Yaw Bediako
- Audio Interviews
- Monthly Newsletter
- Our Profile
- Privacy Policy
- Clinical Case Studies
- Earn HPCSA and SACNASP CPD Points
- Infectious Diseases
- I have spots and my skin burns
- A case of a 10 year old boy with a 3 week history of diarrhoea, vomiting and cough
- A case of fever and general malaise
- A case of persistant hectic fever
- A case of sudden rapid neurological deterioration in an HIV positive 27 year old female
- A case of swollen hands
- An unusual cause of fulminant hepatitis
- Case of a right axillary swelling
- Case of giant wart
- Case of recurrent meningitis
- Case of repeated apnoea and infections in a premature infant
- Case of sudden onset of fever, rash and neck pain
- Doctor, my sister is confused
- Eight month old boy with recurrent infections
- Enlarged Testicles
- Failure to thrive despite appropriate treatment
- Right Axillary Swelling
- Severe anaemia in HIV positive child
- The case of a floppy infant
- Two year old with spiking fevers and depressed level of consciousness
- 17 year old male with fever and decreased level of consciousness
- 3 TB Vignettes
- A 10 year old girl with a hard palate defect
- A case of decreased joint function, fever and rash
- Immunotherapy
- Autoimmune Conditions
- Fireworks of autoimmunity from birth
- My eyes cross at twilight
- A case of a 3 month old infant with bloody urine and stools
- A case of scaly annular plaques
- Case of eye injury and decreased vision
- My head hurts and I cannot speak?
- TB or not TB: a confusing case
- A 7 year old with severe muscle weakness and difficulty walking
- Why can I not walk today?
- 14 year old with severe hip pain
- A 9 year old girl presents with body swelling, shortness of breath and backache
- Drug Responses
- Gastrointestinal Disorders
- Hypersensitivity
- Malignancies
- Mother to Child Transmission
- Primary Immunodeficiencies
- Secondary Immunodeficiencies
- Immunology
- The Basics of the Immune System
- Advanced Immunology
- 1. Transplantation
- 2. Central & Peripheral Tolerance
- 3. Immune Regulation in Pregnancy
- 4. Breaking Tolerance: Autoimmunity & Dysregulation
- 5. Mucosal Immunity & Immunopathology
- 6. Regulation of Immunity & the Microbiome
- 7. Epigenetics & Modulation of Immunity
- 8. Inflammation and autoinflammation
- 9. T cell mediated autoimmune diseases
- 10. Antibody-mediated autoimmune diseases
- Special Focus Area
- Historical Fun Facts
- Online Courses
- Core Immunology Modules
- 1. A Snapshot of the Immune System
- 2. Ontogeny of the Immune System
- 3. The Innate Immune System
- 4. MHC & Antigen Presentation
- 5. Overview of T Cell Subsets
- 6. Thymic T Cell Development
- 7. gamma/delta T Cells
- 8. B Cell Activation and Plasma Cell Differentiation
- 9. Antibody Structure and Classes
- 10. Central and Peripheral Tolerance
- IUIS Courses
- IUIS-FAIS-SANTHE-ISZ Immuno-Zambia 2022
- Immuno-Zambia 2022 Introduction
- A Snapshot of the Immune System
- The Innate Immune System
- MHC & Antigen Presentation
- Overview of T Cell Subsets
- B Cell Activation and Plasma Cell Differentiation
- Antibody Structure and Classes
- Immunity to Viral Infections
- Immunity to SARS-CoV2
- Basic Immunology of HIV
- Immunity to Tuberculosis
- Immunity to Malaria
- Immunity to Schistosomiasis
- Immunity to Helminths
- Equity, Diversity and Inclusion in Academia
- Grant Writing
- IUIS-ALACI-ASCAI2 Immuno-Argentina 2022
- Immuno-Argentina 2022 Introduction
- A Snapshot of the Immune System
- The Innate Immune System
- Dendritic Cells
- Trained Innate Immunity
- MHC & Antigen Presentation
- Overview of T Cell Subsets
- Gamma-Delta T cells
- B cells
- Natural Killer Cell Memory
- Innate Immunity in Viral Infections
- Lectures – Innate Immunity
- T cells and Beyond
- Lectures – Cellular Immunity
- Strategies for Vaccine Design
- Lectures – Humoral Immunity
- Lectures – Vaccine development
- Lectures – Panel and Posters
- IUIS-FAIS-STI Immuno-Tunisia 2021
- Immuno-Tunisia 2021 Introduction
- Core Modules
- Basics of Anti-infectious Immunity
- Inborn Errors of Immunity and Infections
- Infection and Auto-Immunity
- Pathogen-Induced Immune Dysregulation & Cancer
- Understanding of Host-Pathogen Interaction & Applications (SARS-CoV-2)
- Day 1 – Basics of Anti-infectious Immunity
- Day 2 – Inborn Errors of Immunity and Infections
- Day 3 – Infection and Auto-immunity
- Day 4 – Pathogen-induced Immune Dysregulation and Cancer
- Day 5 – Understanding of Host-Pathogen Interaction and Applications (SARS-CoV-2 COVID)
- Student Presentations
- Roundtable Discussions
- Orientation Meeting
- Poster Information
- IUIS-Immunopaedia-ALACI Immuno-Cuba 2022
- IUIS-ALACI-ACAAI Immuno-Colombia 2021
- Immuno-Colombia Introduction
- Core Modules
- Core Modules Meeting
- Overview of Immunotherapy
- Check-Points Blockade Based Therapies
- Cancer Immunotherapy with γδ T cells
- CAR-T, armored CARs and CAR-NK therapies
- Anti-cytokines Therapies
- Tumor-infiltrating Lymphocytes (TIL)
- MDSC Promote Tumor Growth and Escape
- Cancer Vaccines
- Immunological lab methods for patient’s follow-up
- Student Orientation Meeting
- Lectures – Week 1
- Lectures – Week 2
- Student Presentations
- Research Project
- Closing and Social
- IUIS-FAIS Immuno-Algeria 2020
- IUIS-FAIS Immuno-Ethiopia 2020
- Introduction to Immuno-Ethiopia 2020
- Core Modules
- Neutrophils
- Leishmaniasis – Transmission and Epidemiology
- Leishmaniasis – Immune Responses
- Leishmaniasis – Treatment and Vaccines
- Immunity to Helminth Infections
- Helminth immunomodulation on co-infections
- Immunity to Malaria
- Malaria Vaccine Progress
- Immunity to Fungal Infections
- How to be successful scientist
- How to prepare a good academic CV
- IUIS-FAIS-SANTHE-ISZ Immuno-Zambia 2022
- Previous IUIS Courses
- IUIS-FAIS Immuno-Benin
- Introduction to Immuno-Benin
- Core Modules
- Dendritic Cells
- Immune Regulation in Pregnancy
- Immunity in infants and consequence of preeclampsia
- Schistosome infections and impact on Pregnancy
- Infant Immunity and Vaccines
- Regulation of Immunity & the Microbiome
- TGF-beta superfamily in infections and diseases
- Infectious Diseases in the Global Health era
- Immunity to Malaria
- Malaria Vaccine Progress
- Immunity to Toxoplasma gondii
- Immunity to Helminth Infections
- A. melegueta inhibits inflammatory responses during Helminth Infections
- Helminth immunomodulation on co-infections
- Host immune modulation by Helminth-induced products
- Immunity to HIV
- Immunity to Ebola
- Immunity to TB
- Genetic susceptibility in Tuberculosis
- Plant Extract Treatment for Diabetes
- Grant Writing
- IUIS-IDA Immuno-South Africa 2019
- IUIS-IIS-FIMSA Immuno-Jaipur
- Introduction to Immuno-Jaipur
- Core Modules
- Inflammation and autoinflammation
- Central and Peripheral Tolerance
- Autoimmunity and Chronic Inflammatory Diseases
- Autoimmunity & Dysregulation
- Novel Therapeutic strategies for Autoimmune Diseases
- Strategies to apply gamma/delta T cells for Immunotherapy
- Immune Responses to Cancer
- Tumour Microenvironment
- Cancer Immunotherapy
- Origin and perspectives of CAR T cells
- Metabolic checkpoints regulating immune responses
- Transplantation
- Primary Immunodeficiencies
- Regulation of Immunity & the Microbiome
- Growing up with Herpes virus
- IUIS-ALAI-MEXICO-IMMUNOINFORMATICS
- IUIS-FAIS Immuno-Kenya
- Introduction to Immuno-Kenya
- Core Modules
- Viruses hijacking host immune responses
- IFNs as 1st responders to virus infections
- HBV/HCV & Hepatocellular Carcinoma
- Cytokines as biomarkers for HCV
- HTLV & T cell Leukemia
- HCMV and Cancers
- HPV and Cancers
- EBV-induced Oncogenesis
- Adenoviruses
- Immunity to HIV
- KSHV and HIV
- Cancer Immunotherapy
- Ethics in Cancer Research
- Sex and gender in Immunity
- Flow Cytometry
- Group Work
- IUIS-ISIA Immuno-Iran
- IUIS-FAIS-SMI Immuno-Morocco
- IUIS-ALAI Immuno-Brazil
- IUIS-FAIS Immuno-Gambia
- IUIS-IDA Immuno-South Africa 2017
- IUIS-FAIS Immuno-Ethiopia
- IUIS-ALAI-SMI Immuno-Mexico
- Introduction to ONCOIMMUNOLOGY-MEXICO
- ONCOIMMUNOLOGY-MEXICO Photos
- 1. Cancer Epidemiology and Etiology
- 2. T lymphocyte mediated immunity
- 3. Immune Responses to Cancer
- 4. Cancer Stem Cells and Tumor-initiating cells.
- 5. Tumor Microenvironment
- 6. Pathogens and Cancer
- 7. Cancer Immunotherapy
- 8. Flow cytometry approaches in cancer
- IUIS-FAIS Immuno-Tunisia
- Introduction to the Immunology Course
- Immuno-Tunisia Photo
- 1. Overview of the Immune System
- 2. Role of cytokines in Immunity
- 3. Tolerance and autoimmunity
- 4. Genetics, Epigenetics and immunoregulation
- 5. Microbes and immunoregulation
- 6. Inflammation and autoinflammation
- 7. T cell mediated autoimmune diseases
- 8. Antibody-mediated autoimmune diseases
- IUIS-IDA IMMUNO-SOUTH AFRICA
- IUIS-ALAI Immuno-Colombia
- Introduction to the Immunology Course
- Immuno-Colombia Photo
- 1. Overview of Complement
- 2. Transplantation
- 3. Immune Regulation in Pregnancy
- 4. Breaking Tolerance: Autoimmunity & Dysregulation
- 5. Mucosal Immunity & Immunopathology
- 6. Regulation of Immunity & the Microbiome
- 7. Epigenetics & Modulation of Immunity
- 8. Primary Immunodeficiencies
- 9. Anti-tumour Immunity
- 10. Cancer Immunotherapy
- IUIS-FAIS Immuno-Benin
- Other Courses
- 11th IDA 2022
- 11th IDA 2022 Introduction
- A Snapshot of the Immune System
- The Innate Immune System
- MHC & Antigen Presentation
- Overview of T Cell Subsets
- B Cell Activation and Plasma Cell Differentiation
- Antibody Structure and Classes
- Immunity to COVID-19
- Immunity to TB
- Immunity to HIV
- Immunity to Malaria
- Grant Writing
- AfriBop 2022
- SUN Honours
- SUN Honours Introduction
- A Snapshot of the Immune System
- Ontogeny of the Immune System
- The Innate Immune System
- MHC & Antigen Presentation
- Overview of T Cell Subsets
- B Cell Activation and Plasma Cell Differentiation
- Antibody Structure and Classes
- Cellular Immunity and Immunological Memory
- Infectious Diseases Immunology
- Vaccinology
- Immune Regulation in Pregnancy
- Mucosal Immunity & Immunopathology
- Central & Peripheral Tolerance
- Regulation of Immunity & the Microbiome
- Epigenetics & Modulation of Immunity
- T cell and Ab-mediated autoimmune diseases
- Transplantation
- Immunology of COVID-19 Vaccines
- Biomarkers
- Flow Cytometry
- AfriBop 2021
- 10th IDA 2021
- Immunity to Pathogens
- Afribop 2020
- VACFA AAVC 2020
- UCT Advanced Immunology
- A Snapshot of the Immune System
- Ontogeny of the Immune System
- The Innate Immune System
- MHC & Antigen Presentation
- Overview of T Cell Subsets
- Thymic T Cell Development
- B Cell Activation and Plasma Cell Differentiation
- Antibody Structure and Classes
- Central and Peripheral Tolerance
- Immune Escape
- Immunity to Viral Infections
- Immunity to TB
- Immunity to Helminth Infections
- Introduction to Immunization Strategies
- Immune Responses to Vaccination
- Infant Immunity and Vaccines
- Breaking Tolerance: Autoimmunity & Dysregulation
- Primary Immunodeficiencies
- Genetics, Epigenetics and immunoregulation
- Immunity to Fungal Infections
- Regulation of Immunity & the Microbiome
- Flow Cytometry
- IDA 2018
- 11th IDA 2022
- Core Immunology Modules
- Webinars
- SAIS/Immunopaedia Webinars 2022
- IUIS – Immunopaedia – Frontiers Webinars 2022
- Metabolic control of T cell differentiation during immune responses to cancer
- Microbiome control of host immunity
- Shaping of anti-tumor immunity in the tumor microenvironment
- The unusual COVID-19 pandemic: the African story
- Immune responses to SARS-CoV-2
- Adaptive Immunity and Immune Memory to SARS-CoV-2 after COVID-19
- IUIS – Immunopaedia – Frontiers Webinars
- HIV prevention- antibodies and vaccine development (part 2)
- HIV prevention- antibodies and vaccine development (part 1)
- Immunopathology of COVID 19 lessons from pregnancy and from ageing
- Clinical representation of hyperinflammation
- In-depth characterisation of immune cells in Ebola virus
- Getting to the “bottom” of arthritis
- Immunoregulation and the tumor microenvironment
- Harnessing innate immunity from cancer therapy to COVID-19
- Flynn Webinar: Immune features associated natural infection
- Flynn Webinar: What immune cells play a role in protection against M.tb re-infection?
- JoAnne Flynn: BCG IV vaccination induces sterilising M.tb immunity
- IUIS-Immunopaedia-Frontiers Webinar on Immunology taught by P. falciparum
- SAIS/Immunopaedia Webinars
- Collaborations
- Treatment & Diagnostics
- Glossary
- Our Ambassadors
- Ambassador of the Month – 2022
- Africa
- Asia
- Europe
- North America
- Oceania
- South America
- The Day of Immunology 2022
- AMBASSADOR SCI-TALKS
- The Day of Immunology 2021
- Ambassador of the Month – 2021
- Ambassador of the Month-2020
- Ambassador of the Month – 2019
- Ambassador of the Month – 2018
- Ambassador of the Month – 2017
- Course Registrations
